{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:57Z","timestamp":1790915877649,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.bbr.2004.08.015","type":"journal-article","created":{"date-parts":[[2004,9,28]],"date-time":"2004-09-28T17:43:05Z","timestamp":1096393385000},"page":"123-132","source":"Crossref","is-referenced-by-count":74,"title":["Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania"],"prefix":"10.1016","volume":"158","author":[{"given":"Roberto","family":"Arban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Maraia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Brackenborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Winyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gerrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Large","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2004.08.015_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1749-6632.1995.tb44720.x","article-title":"Stress, conditioning and the temporal aspects of affective disorders","volume":"771","author":"Post","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbr.2004.08.015_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00004850-198807000-00001","article-title":"The clinical uses and pharmacology of carbamazepine in psychiatry","volume":"3","author":"Elphick","year":"1988","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2004.08.015_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004850-200015010-00001","article-title":"Current aspects of valproate in bipolar disorder","volume":"15","author":"Lennkh","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2004.08.015_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10673220127901","article-title":"Antiepileptic drugs for the acute and maintenance treatment of bipolar disorder","volume":"9","author":"De Leon","year":"2001","journal-title":"Harvard Rev Psych"},{"key":"10.1016\/j.bbr.2004.08.015_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0006-3223(00)00961-6","article-title":"Pharmacologic agents for the treatment of acute bipolar mania","volume":"48","author":"McElroy","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.mp.4001013","article-title":"What makes a drug a primary mood stabiliser?","volume":"7","author":"Keck","year":"2002","journal-title":"Mol Psych"},{"key":"10.1016\/j.bbr.2004.08.015_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1528-1157.1995.tb06002.x","article-title":"Lamotrigine","volume":"36","author":"Messenheimer","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2004.08.015_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1517\/13543784.10.4.661","article-title":"Novel treatments for bipolar disorder","volume":"10","author":"Bowden","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bbr.2004.08.015_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4088\/JCP.v58n1202","article-title":"Lamotrigine in rapid-cycling bipolar disorder","volume":"58","author":"Fatemi","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0006-3223(99)00198-5","article-title":"The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder","volume":"46","author":"Hamer","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0006-3223(99)00013-X","article-title":"The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder","volume":"45","author":"Bowden","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1176\/ajp.156.7.1019","article-title":"Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder","volume":"156","author":"Calabrese","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/10401230009147081","article-title":"Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial","volume":"12","author":"Ichim","year":"2000","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.jcp.0000088915.02635.e8","article-title":"Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders","volume":"23","author":"Ketter","year":"2003","journal-title":"J Clin Psychopharm"},{"key":"10.1016\/j.bbr.2004.08.015_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s002130050117","article-title":"The place of anticonvulsant therapy in bipolar illness","volume":"128","author":"Post","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2004.08.015_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2004.08.015_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal (lamotrigine) monotherapy for typical absence seizures in children","volume":"140","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbr.2004.08.015_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1469-8749.1998.tb15409.x","article-title":"Inappropriate use of carbamazepine and vigabatrin in typical absence seizures","volume":"40","author":"Parker","year":"1998","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.bbr.2004.08.015_bib20","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/2111312a0","article-title":"Combined effects of chlordiazepoxide and d-amphetamine on activity of rats in an unfamiliar environment","volume":"211","author":"Rushton","year":"1966","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2004.08.015_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00217062","article-title":"Hyperactivity induced by dexd-amphetamine\/chlordiazepoxide mixtures in rats and its attenuation by lithium pretreatment: a role for dopamine?","volume":"91","author":"Aylmer","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2004.08.015_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF00518190","article-title":"Effect of lithium administration on rat brain 5-hydroxyindole levels in a possible model for mania","volume":"91","author":"Vale","year":"1987","journal-title":"Psychopharm"},{"key":"10.1016\/j.bbr.2004.08.015_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(93)90266-K","article-title":"Magnesium valproate attenuates hyperactivity induced by dexd-amphetamine-chlordiazepoxide mixture in rodents","volume":"237","author":"Cao","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2004.08.015_bib24","first-page":"533","article-title":"Chlordiazepoxide\/d-amphetamine induced hyperactivity in rats: assessment as mania model using automated activity chambers","volume":"25","author":"Serpa","year":"1999","journal-title":"Soc Neurosci Abstr"},{"key":"10.1016\/j.bbr.2004.08.015_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/ebeh.2001.0254","article-title":"Effect of the new antiepileptic drug levetiracetam in an animal model of mania","volume":"2","author":"Lamberty","year":"2001","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.bbr.2004.08.015_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002130050227","article-title":"Maintenance of d-amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation","volume":"130","author":"Conti","year":"1997","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.bbr.2004.08.015_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-0173(89)90003-9","article-title":"Animal models of the epilepsies","volume":"14","author":"Fisher","year":"1989","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bbr.2004.08.015_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4088\/JCP.v63n0210","article-title":"Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature","volume":"63","author":"Ketter","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/joe.0.0400391","article-title":"Changes in plasma cortisol induced by dexd-amphetamine and chlordiazepoxide given alone and in combination in man","volume":"40","author":"Butler","year":"1967","journal-title":"J Endocr"},{"key":"10.1016\/j.bbr.2004.08.015_bib30","first-page":"977","article-title":"The interaction of chlordiazepoxide and d-amphetamine in man","volume":"22","author":"Besser","year":"1967","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.bbr.2004.08.015_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-3223(95)00133-6","article-title":"Prolactin and cortisol responses to fenfluramine challenge in mania","volume":"39","author":"Yatham","year":"1996","journal-title":"Biol Psych"},{"key":"10.1016\/j.bbr.2004.08.015_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0006-3223(93)90252-9","article-title":"Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders","volume":"34","author":"Yehuda","year":"1993","journal-title":"Biol. Psych"},{"key":"10.1016\/j.bbr.2004.08.015_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archpsyc.1994.03950080028004","article-title":"The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania","volume":"51","author":"Linkowski","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanism of action of valproate: a commentary","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2004.08.015_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0269881103017002004","article-title":"GABA-ergic drugs: exit stage left, enter stage right","volume":"17","author":"Ashton","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"Suppl. 3","key":"10.1016\/j.bbr.2004.08.015_bib36","first-page":"15","article-title":"The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders","volume":"64","author":"Ketter","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib37","first-page":"213","article-title":"The mechanism of action of tiagabine","volume":"12","author":"Walker","year":"2002","journal-title":"Rev Contemp Pharmacother"},{"issue":"Suppl. 8","key":"10.1016\/j.bbr.2004.08.015_bib38","first-page":"9","article-title":"Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders","volume":"64","author":"Evins","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib39","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharm"},{"key":"10.1016\/j.bbr.2004.08.015_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(00)00196-0","article-title":"Chronic lamotrigine treatment increases rat hippocampal GABA shunt activity and elevates cerebral taurine levels","volume":"43","author":"Hassel","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.bbr.2004.08.015_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/WNL.58.3.368","article-title":"Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults","volume":"58","author":"Kuzniecky","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2004.08.015_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00213-003-1421-2","article-title":"Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice","volume":"169","author":"Brody","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2004.08.015_bib43","unstructured":"Idris N, Neill J, Large CH. Lamotrigine reverses disruption of the serial reversal task by PCP in rats. Psychopharmacology (submitted)."},{"key":"10.1016\/j.bbr.2004.08.015_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharm"},{"key":"10.1016\/j.bbr.2004.08.015_bib45","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2004.08.015_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1098-2396(199611)24:3<248::AID-SYN7>3.0.CO;2-E","article-title":"Presynaptic inhibition of excitatory neurotransmission by lamotrigine in rat amygdalar neurons","volume":"24","author":"Wang","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2004.08.015_bib47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bjp.0702361","article-title":"An in vitro electrophysiological study of the effects of phenytoin, lamotrigine and gabapentin on striatal neurons","volume":"126","author":"Calabresi","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2004.08.015_bib48","first-page":"437","article-title":"Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIa Na+ channels and with native Na+ channels in rat hippocampal neurones","volume":"430","author":"Xie","year":"1995","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.bbr.2004.08.015_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000026527","article-title":"Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder","volume":"38","author":"Xie","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bbr.2004.08.015_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0773.2002.900407.x","article-title":"Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices","volume":"90","author":"Cunha","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2004.08.015_bib51","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.45.10.1907","article-title":"Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters","volume":"45","author":"Waldmeier","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2004.08.015_bib52","first-page":"549","article-title":"Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells","volume":"27","author":"Willow","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2004.08.015_bib53","first-page":"712","article-title":"A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuron neuronal Na+ channels","volume":"54","author":"Kuo","year":"1998","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbr.2004.08.015_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(92)90579-S","article-title":"Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-d-aspartate-induced intracellular Ca2+ levels in neuronal culture","volume":"219","author":"Cai","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2004.08.015_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF02124294","article-title":"Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA\/2 mice","volume":"48","author":"Lancaster","year":"1992","journal-title":"Experientia"},{"key":"10.1016\/j.bbr.2004.08.015_bib56","first-page":"143","article-title":"Carbamazepine inhibition of N-methyl-d-aspartate-evoked calcium influx in rat cerebellar granule cells","volume":"276","author":"Hough","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2004.08.015_bib57","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0028-3908(99)00058-1","article-title":"Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists","volume":"38","author":"Ambrosio","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2004.08.015_bib58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/seiz.2000.0428","article-title":"A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure","volume":"9","author":"Gillham","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.bbr.2004.08.015_bib59","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1073\/pnas.94.9.4757","article-title":"The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates","volume":"94","author":"Dixon","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2004.08.015_bib60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s002210000443","article-title":"Molecular regulation of glutamate and GABA transporter proteins by valproic acid in rat hippocampus during epileptogenesis","volume":"133","author":"Ueda","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bbr.2004.08.015_bib61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatric Res"},{"key":"10.1016\/j.bbr.2004.08.015_bib62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/35077553","article-title":"Neuromodulation of Na+ channels: an unexpected form of cellular plasticity.","volume":"2","author":"Cantrell","year":"2001","journal-title":"Nat Rev (Neurosci)"},{"key":"10.1016\/j.bbr.2004.08.015_bib63","first-page":"239","article-title":"Studies of the lethargic (lh\/lh) mouse model of absence seizures: regulatory mechanisms and identification of the lh gene","volume":"79","author":"Hosford","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bbr.2004.08.015_bib64","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/0883073897012001031","article-title":"Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?","volume":"12","author":"Coulter","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1016\/j.bbr.2004.08.015_bib65","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archpsyc.56.10.950","article-title":"Clozapine plus lamotrigine in treatment-resistant schizophrenia (letter)","volume":"56","author":"Dursun","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib66","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0006-3223(03)00524-9","article-title":"Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial","volume":"54","author":"Tiihonen","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-3223(85)90085-X","article-title":"Effect of valproic acid on behavior and plasma amino acid concentrations in chronic schizophrenic patients","volume":"20","author":"Ko","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archpsyc.1991.01810250071010","article-title":"Carbamazepine maintenance treatment in outpatient schizophrenics","volume":"48","author":"Carpenter","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2007-979312","article-title":"Combined treatment of schizophrenic psychoses with haloperidol and valproate","volume":"31","author":"Dose","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.bbr.2004.08.015_bib70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004714-199908000-00005","article-title":"Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients","volume":"19","author":"Hesslinger","year":"1999","journal-title":"J Clin Psychopharmacol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432804003389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432804003389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T12:28:02Z","timestamp":1705235282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432804003389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0166432804003389"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2004.08.015","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}